115 related articles for article (PubMed ID: 25653490)
1. Rapid increase of health care utilization and cost due to benign prostatic hyperplasia in Korean men: retrospective population-based analysis using the Health Insurance Review and Assessment service data.
Son H; Park J; Song SH; Kang JY; Hong SK; Lee HM; Kim SH; Park BJ; Lee HL; Lee KS
J Korean Med Sci; 2015 Feb; 30(2):180-5. PubMed ID: 25653490
[TBL] [Abstract][Full Text] [Related]
2. Comparison of health care costs and co-morbidities between men diagnosed with benign prostatic hyperplasia and cardiovascular disease (CVD) and men with CVD alone in a US commercial population.
Shah M; Butler M; Bramley T; Curtice TG; Fine S
Curr Med Res Opin; 2007 Feb; 23(2):417-26. PubMed ID: 17288695
[TBL] [Abstract][Full Text] [Related]
3. Healthcare utilization and costs in patients with benign prostatic hyperplasia: a population-based study.
Chung SD; Tzeng YM; Lin HC; Huang CY
Asian J Androl; 2016; 18(6):942-945. PubMed ID: 26585701
[TBL] [Abstract][Full Text] [Related]
4. Comparative analysis of benign prostatic hyperplasia management by urologists and nonurologists: a Korean nationwide health insurance database study.
Park J; Lee YJ; Lee JW; Yoo TK; Chung JI; Yun SJ; Hong JH; Seo SI; Cho SY; Son H
Korean J Urol; 2015 Mar; 56(3):233-9. PubMed ID: 25763128
[TBL] [Abstract][Full Text] [Related]
5. Economic costs of benign prostatic hyperplasia in the private sector.
Saigal CS; Joyce G
J Urol; 2005 Apr; 173(4):1309-13. PubMed ID: 15758787
[TBL] [Abstract][Full Text] [Related]
6. Annual costs of benign prostatic hyperplasia in New Zealand.
Scott WG; Scott HM
Pharmacoeconomics; 1993 Dec; 4(6):455-68. PubMed ID: 10151048
[TBL] [Abstract][Full Text] [Related]
7. Nationwide incidence and treatment pattern of benign prostatic hyperplasia in Korea.
Lee YJ; Lee JW; Park J; Seo SI; Chung JI; Yoo TK; Son H
Investig Clin Urol; 2016 Nov; 57(6):424-430. PubMed ID: 27847916
[TBL] [Abstract][Full Text] [Related]
8. Burden of male lower urinary tract symptoms (LUTS) suggestive of benign prostatic hyperplasia (BPH) - focus on the UK.
Speakman M; Kirby R; Doyle S; Ioannou C
BJU Int; 2015 Apr; 115(4):508-19. PubMed ID: 24656222
[TBL] [Abstract][Full Text] [Related]
9. A cost density analysis of benign prostatic hyperplasia.
Lanes SF; Sulsky S; Walker AM; Isen J; Grier CE; Lewis BE; Dreyer NA
Clin Ther; 1996; 18(5):993-1004. PubMed ID: 8930437
[TBL] [Abstract][Full Text] [Related]
10. The economics of benign prostatic hyperplasia treatment: a literature review.
Kortt MA; Bootman JL
Clin Ther; 1996; 18(6):1227-41. PubMed ID: 9001839
[TBL] [Abstract][Full Text] [Related]
11. Benign prostatic hyperplasia in Sweden 1987 to 1994: changing patterns of treatment, changing patterns of costs.
Blomqvist P; Ekbom A; Carlsson P; Ahlstrand C; Johansson JE
Urology; 1997 Aug; 50(2):214-9; discussion 219-20. PubMed ID: 9255291
[TBL] [Abstract][Full Text] [Related]
12. An evaluation of universal health insurance in the elderly: burden of disease, utilization, and costs in the Republic of Korea.
Peabody JW; Robalino DA; Kim JH
J Aging Health; 2002 May; 14(2):286-309. PubMed ID: 11995744
[TBL] [Abstract][Full Text] [Related]
13. Economic modeling to assess the costs of treatment with finasteride, terazosin, and transurethral resection of the prostate for men with moderate to severe symptoms of benign prostatic hyperplasia.
Lowe FC; McDaniel RL; Chmiel JJ; Hillman AL
Urology; 1995 Oct; 46(4):477-83. PubMed ID: 7571214
[TBL] [Abstract][Full Text] [Related]
14. A population based study of incidence and treatment of benign prostatic hyperplasia among residents of Olmsted County, Minnesota: 1987 to 1997.
Sarma AV; Jacobson DJ; McGree ME; Roberts RO; Lieber MM; Jacobsen SJ
J Urol; 2005 Jun; 173(6):2048-53. PubMed ID: 15879823
[TBL] [Abstract][Full Text] [Related]
15. The differences in health care utilization between Medical Aid and health insurance: a longitudinal study using propensity score matching.
Kim JH; Lee KS; Yoo KB; Park EC
PLoS One; 2015; 10(3):e0119939. PubMed ID: 25816234
[TBL] [Abstract][Full Text] [Related]
16. Health Care Utilization for Common Shoulder Disorders: Analysis of the 2010-2019 National Patient Sample Data from the Health Insurance Review and Assessment Service in Korea.
Kang JY; Kim D; Kim H; Ha IH; Lee YJ
Medicina (Kaunas); 2024 Apr; 60(5):. PubMed ID: 38792927
[No Abstract] [Full Text] [Related]
17. Urologic diseases in America project: benign prostatic hyperplasia.
Wei JT; Calhoun E; Jacobsen SJ
J Urol; 2005 Apr; 173(4):1256-61. PubMed ID: 15758764
[TBL] [Abstract][Full Text] [Related]
18. Effect of health insurance type on health care utilization in patients with hypertension: a national health insurance database study in Korea.
Suh HS; Kang HY; Kim J; Shin E
BMC Health Serv Res; 2014 Nov; 14():570. PubMed ID: 25412904
[TBL] [Abstract][Full Text] [Related]
19. Community-based research on the benign prostatic hyperplasia prevalence rate in Korean rural area.
Goh HJ; Kim SA; Nam JW; Choi BY; Moon HS
Korean J Urol; 2015 Jan; 56(1):68-75. PubMed ID: 25598939
[TBL] [Abstract][Full Text] [Related]
20. Patient characteristics and treatment patterns for patients with benign prostatic hyperplasia, erectile dysfunction or co-occurring benign prostatic hyperplasia and erectile dysfunction in general practices in the UK: a retrospective observational study.
Ilo D; Raluy-Callado M; Graham-Clarke P; Sadasivan R; Birt J; Donaldson R; Zhu E; Kirby MG; Neasham D
Int J Clin Pract; 2015 Aug; 69(8):853-62. PubMed ID: 26011100
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
